Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$22.30
+1.4%
$27.54
$20.19
$59.61
$1.06B1.41714,914 shs899,399 shs
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$80.37
$82.48
$39.40
$89.76
$3.58B1.55626,604 shsN/A
Glaukos Co. stock logo
GKOS
Glaukos
$110.45
+2.6%
$95.09
$54.38
$111.39
$5.29B1.08456,679 shs322,589 shs
Luminex Co. stock logo
LMNX
Luminex
$36.99
$36.90
$20.61
$41.69
$1.75B0.56873,093 shsN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$80.83
+0.9%
$74.33
$62.58
$85.62
$4.62B0.91352,911 shs345,023 shs
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
+6.33%-0.99%-20.32%-33.17%-55.11%
Cantel Medical Corp. stock logo
CMD
Cantel Medical
0.00%0.00%0.00%0.00%0.00%
Glaukos Co. stock logo
GKOS
Glaukos
+0.68%+2.39%+6.37%+11.85%+81.92%
Luminex Co. stock logo
LMNX
Luminex
0.00%0.00%0.00%0.00%0.00%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
+1.26%+4.01%+10.48%+0.16%-5.23%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AtriCure, Inc. stock logo
ATRC
AtriCure
3.6573 of 5 stars
4.54.00.00.01.92.50.6
Cantel Medical Corp. stock logo
CMD
Cantel Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Glaukos Co. stock logo
GKOS
Glaukos
3.5759 of 5 stars
2.41.00.04.43.72.50.6
Luminex Co. stock logo
LMNX
Luminex
N/AN/AN/AN/AN/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
4.6278 of 5 stars
3.42.00.03.82.72.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
3.00
Buy$49.78123.22% Upside
Cantel Medical Corp. stock logo
CMD
Cantel Medical
N/AN/AN/AN/A
Glaukos Co. stock logo
GKOS
Glaukos
2.82
Moderate Buy$108.64-1.64% Downside
Luminex Co. stock logo
LMNX
Luminex
N/AN/AN/AN/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
2.89
Moderate Buy$92.7814.78% Upside

Current Analyst Ratings

Latest CMD, MMSI, GKOS, ATRC, and LMNX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2024
Glaukos Co. stock logo
GKOS
Glaukos
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$84.00 ➝ $125.00
5/2/2024
AtriCure, Inc. stock logo
ATRC
AtriCure
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$57.00 ➝ $49.00
5/2/2024
AtriCure, Inc. stock logo
ATRC
AtriCure
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$42.00 ➝ $34.00
5/2/2024
AtriCure, Inc. stock logo
ATRC
AtriCure
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$46.00 ➝ $40.00
5/2/2024
Glaukos Co. stock logo
GKOS
Glaukos
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$107.00 ➝ $112.00
5/2/2024
Glaukos Co. stock logo
GKOS
Glaukos
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$108.00 ➝ $110.00
5/2/2024
Glaukos Co. stock logo
GKOS
Glaukos
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$120.00 ➝ $125.00
5/2/2024
Glaukos Co. stock logo
GKOS
Glaukos
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$103.00 ➝ $110.00
5/2/2024
Glaukos Co. stock logo
GKOS
Glaukos
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$108.00 ➝ $113.00
5/1/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$112.00 ➝ $102.00
5/1/2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$98.00 ➝ $100.00
(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$414.60M2.56N/AN/A$9.84 per share2.27
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$1.02B3.52$3.38 per share23.78$17.31 per share4.64
Glaukos Co. stock logo
GKOS
Glaukos
$314.71M17.68N/AN/A$8.95 per share12.34
Luminex Co. stock logo
LMNX
Luminex
$417.40M4.19$1.12 per share32.98$11.13 per share3.32
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$1.26B3.74$4.91 per share16.47$21.34 per share3.79

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$30.44M-$0.80N/AN/AN/A-8.98%-7.85%-6.05%7/23/2024 (Estimated)
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$13.71M$1.6569.2828.911.634.72%12.13%4.45%N/A
Glaukos Co. stock logo
GKOS
Glaukos
-$134.66M-$2.88N/AN/AN/A-43.15%-24.69%-12.27%8/7/2024 (Estimated)
Luminex Co. stock logo
LMNX
Luminex
$15.17M$0.3272.5330.83N/A5.39%4.66%2.91%N/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$94.41M$1.7446.4522.152.227.94%15.02%8.83%7/23/2024 (Estimated)

Latest CMD, MMSI, GKOS, ATRC, and LMNX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024Q1 2024
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.23-$0.25-$0.02-$0.22$106.86 million$108.90 million      
5/1/2024Q1 2024
Glaukos Co. stock logo
GKOS
Glaukos
-$0.58-$0.70-$0.12-$0.58$79.60 million$85.60 million    
4/30/2024Q1 2024
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.71$0.77+$0.06$1.06$315.57 million$323.51 million    
2/28/2024Q4 2023
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
$0.77$0.81+$0.04$1.15$320.66 million$324.52 million    
2/21/2024Q4 2023
Glaukos Co. stock logo
GKOS
Glaukos
-$0.56-$0.63-$0.07-$0.51$81.00 million$82.40 million    
2/15/2024Q4 2023
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.22-$0.21+$0.01-$0.21$103.68 million$106.50 million      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Cantel Medical Corp. stock logo
CMD
Cantel Medical
$0.210.26%N/A12.73%N/A
Glaukos Co. stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
Luminex Co. stock logo
LMNX
Luminex
$0.401.08%N/A125.00%N/A
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.16
4.00
2.83
Cantel Medical Corp. stock logo
CMD
Cantel Medical
1.16
2.72
2.00
Glaukos Co. stock logo
GKOS
Glaukos
0.78
5.38
4.68
Luminex Co. stock logo
LMNX
Luminex
0.52
8.37
6.08
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
0.65
6.03
4.38

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Cantel Medical Corp. stock logo
CMD
Cantel Medical
84.13%
Glaukos Co. stock logo
GKOS
Glaukos
99.04%
Luminex Co. stock logo
LMNX
Luminex
87.76%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
99.66%

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
3.20%
Cantel Medical Corp. stock logo
CMD
Cantel Medical
10.70%
Glaukos Co. stock logo
GKOS
Glaukos
6.40%
Luminex Co. stock logo
LMNX
Luminex
6.60%
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
3.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,20047.59 million46.07 millionOptionable
Cantel Medical Corp. stock logo
CMD
Cantel Medical
3,66944.51 millionN/AOptionable
Glaukos Co. stock logo
GKOS
Glaukos
90750.37 million46.98 millionOptionable
Luminex Co. stock logo
LMNX
Luminex
1,32547.31 millionN/AOptionable
Merit Medical Systems, Inc. stock logo
MMSI
Merit Medical Systems
6,95058.11 million55.96 millionOptionable

CMD, MMSI, GKOS, ATRC, and LMNX Headlines

SourceHeadline
Merit Medical Systems, Inc. (NASDAQ:MMSI) Position Increased by M&T Bank CorpMerit Medical Systems, Inc. (NASDAQ:MMSI) Position Increased by M&T Bank Corp
marketbeat.com - May 9 at 6:32 AM
Merit Medical Systems, Inc. (NASDAQ:MMSI) Position Decreased by Fisher Asset Management LLCMerit Medical Systems, Inc. (NASDAQ:MMSI) Position Decreased by Fisher Asset Management LLC
marketbeat.com - May 6 at 6:45 AM
Research Analysts Issue Forecasts for Merit Medical Systems, Inc.s Q2 2024 Earnings (NASDAQ:MMSI)Research Analysts Issue Forecasts for Merit Medical Systems, Inc.'s Q2 2024 Earnings (NASDAQ:MMSI)
americanbankingnews.com - May 6 at 1:40 AM
Channing Capital Management LLC Has $55.31 Million Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)Channing Capital Management LLC Has $55.31 Million Stake in Merit Medical Systems, Inc. (NASDAQ:MMSI)
marketbeat.com - May 5 at 11:34 PM
Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives Average Recommendation of "Moderate Buy" from BrokeragesMerit Medical Systems, Inc. (NASDAQ:MMSI) Receives Average Recommendation of "Moderate Buy" from Brokerages
americanbankingnews.com - May 5 at 1:28 AM
Needham & Company LLC Trims Merit Medical Systems (NASDAQ:MMSI) Target Price to $85.00Needham & Company LLC Trims Merit Medical Systems (NASDAQ:MMSI) Target Price to $85.00
americanbankingnews.com - May 4 at 6:14 AM
Piper Sandler Boosts Merit Medical Systems (NASDAQ:MMSI) Price Target to $97.00Piper Sandler Boosts Merit Medical Systems (NASDAQ:MMSI) Price Target to $97.00
americanbankingnews.com - May 4 at 5:36 AM
Barrington Research Boosts Merit Medical Systems (NASDAQ:MMSI) Price Target to $100.00Barrington Research Boosts Merit Medical Systems (NASDAQ:MMSI) Price Target to $100.00
americanbankingnews.com - May 4 at 5:36 AM
Merit Medical Systems, Inc. (NASDAQ:MMSI) Forecasted to Post FY2024 Earnings of $3.35 Per ShareMerit Medical Systems, Inc. (NASDAQ:MMSI) Forecasted to Post FY2024 Earnings of $3.35 Per Share
americanbankingnews.com - May 4 at 3:26 AM
Merit Medical Systems, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This YearMerit Medical Systems, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
finance.yahoo.com - May 3 at 10:31 AM
Brokers Set Expectations for Merit Medical Systems, Inc.s FY2024 Earnings (NASDAQ:MMSI)Brokers Set Expectations for Merit Medical Systems, Inc.'s FY2024 Earnings (NASDAQ:MMSI)
marketbeat.com - May 3 at 9:59 AM
Merit Medical Systems (NASDAQ:MMSI) Price Target Cut to $102.00Merit Medical Systems (NASDAQ:MMSI) Price Target Cut to $102.00
americanbankingnews.com - May 3 at 5:18 AM
Merit Health Wesley hires new chief executive officerMerit Health Wesley hires new chief executive officer
msn.com - May 2 at 10:35 AM
Merit Medical Systems First Quarter 2024 Earnings: Beats ExpectationsMerit Medical Systems First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - May 2 at 10:35 AM
Merit Medical Systems (NASDAQ:MMSI) Rating Increased to Buy at StockNews.comMerit Medical Systems (NASDAQ:MMSI) Rating Increased to Buy at StockNews.com
americanbankingnews.com - May 2 at 5:16 AM
Men of Merit: UCI HealthMen of Merit: UCI Health
msn.com - May 1 at 6:56 PM
The Analyst Landscape: 11 Takes On Merit Medical SystemsThe Analyst Landscape: 11 Takes On Merit Medical Systems
markets.businessinsider.com - May 1 at 6:56 PM
Merit Medical Systems (NASDAQ:MMSI) PT Lowered to $102.00Merit Medical Systems (NASDAQ:MMSI) PT Lowered to $102.00
marketbeat.com - May 1 at 3:06 PM
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)
markets.businessinsider.com - May 1 at 1:55 PM
Bank of America Securities Keeps Their Hold Rating on Merit Medical Systems (MMSI)Bank of America Securities Keeps Their Hold Rating on Merit Medical Systems (MMSI)
markets.businessinsider.com - May 1 at 1:55 PM
Merit Medical (MMSI) Q1 Earnings Top Estimates, Margins UpMerit Medical (MMSI) Q1 Earnings Top Estimates, Margins Up
zacks.com - May 1 at 1:50 PM
Merit Medical Systems (NASDAQ:MMSI) Issues Quarterly  Earnings Results, Beats Expectations By $0.06 EPSMerit Medical Systems (NASDAQ:MMSI) Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS
marketbeat.com - May 1 at 8:38 AM
Merit Medical Systems Inc (MMSI) Q1 2024 Earnings Call Transcript Highlights: Strong ...Merit Medical Systems Inc (MMSI) Q1 2024 Earnings Call Transcript Highlights: Strong ...
finance.yahoo.com - May 1 at 3:54 AM
MMSI Stock Earnings: Merit Medical Systems Beats EPS, Beats Revenue for Q1 2024MMSI Stock Earnings: Merit Medical Systems Beats EPS, Beats Revenue for Q1 2024
markets.businessinsider.com - April 30 at 10:54 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

AtriCure logo

AtriCure

NASDAQ:ATRC
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Cantel Medical logo

Cantel Medical

NYSE:CMD
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.
Glaukos logo

Glaukos

NYSE:GKOS
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
Luminex logo

Luminex

NASDAQ:LMNX
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
Merit Medical Systems logo

Merit Medical Systems

NASDAQ:MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.